SOPREFERENCE OUTLINE

Hybrid Record Definition and Control

Definition and control for processes running on both paper and a system: which components together form one record, a two-way link between the halves, review that sees both, electronic controls for the electronic half regardless of the wet signature, matched retention archived linked, and a stated transition intention. Maps to the FDA data integrity and CGMP Q&A and PIC/S PI 041-1.

What a template is not

A template is a document baseline to adapt inside your own quality system. SPEQ does not approve, validate, or take responsibility for what you issue from it, and using one is not evidence of compliance.

CHECKING ACCESS

Checking your Professional access…

REGULATIONS MAPPED
FDA DI & CGMP Q&A (2018)PIC/S PI 041-1
DOCUMENT TYPE
SOP
LAST UPDATED
August 2026
PURPOSE

Hybrid systems are common, permitted, and the hardest arrangement to keep defensible, because the record is split and the two halves can drift apart, be reviewed separately, or be retained on different schedules. Nobody sets out to build a hybrid; they accumulate. Defining which components together form one complete record is your organisation’s determination, and nothing downstream is defensible until it is written down.

What's Inside

✓A per-process statement of which components together form one complete record, paper and electronic
✓A two-way link between the halves, so retrieval works from either direction rather than only one
✓Review arrangements requiring both halves to be seen before any signature is applied over them
✓The electronic controls the electronic half needs regardless of a wet signature on the paper half
✓Matched retention periods, with both halves archived linked rather than by their own media rules
✓Roles and access, so the person signing the paper can actually reach the electronic data and its audit trail
✓A stated transition intention with a target date, so the hybrid is a decision rather than a default

How to Use It

1Define the complete record first; if nobody can say which components make one, nothing downstream — review, retention or retrieval — is defensible.
2Make the link two-way, because a one-way reference fails retrieval in exactly the direction you did not plan for.
3Do not let a paper signature certify half a record — the reviewer must have seen the electronic data and its audit trail.
4Apply the controls the electronic half needs on its own merits; a wet signature on paper does not substitute for any of them.
5Retain both halves for the same period and archive them linked, or the electronic half disappears with a replaced workstation.
6State the transition intention and a date, so the arrangement stays a documented decision rather than an accumulation nobody owns.
DOCUMENT CONTENTS

The full section structure of this template — every section and sub-section, so you can use it as a baseline for your own site document.

—Document Control
› Document Information› Approval Signatures› Revision History› Distribution List
1What Forms the Complete Record
2Linking the Halves
3Review of Both Halves Together
4Controls the Electronic Half Needs
5Retention
6Transition Intention
REGULATORY CONTEXT

The FDA data integrity and CGMP questions-and-answers guidance (2018) addresses hybrid systems and the controls each component requires, and PIC/S PI 041-1 sets the corresponding data integrity expectations for inspectorates, covering record completeness, review and retention. Neither defines the boundary of your record, which processes may stay hybrid, or when you should transition away. Those are your organisation’s determinations, and inspectors ask to see them stated rather than inferred. The definition structure is SPEQ practitioner synthesis.

MAPPED STANDARDS
FDA DI & CGMP Q&A (2018)PIC/S PI 041-1
Browse the standards catalog →